Add-on effect of homeopathy in the treatment of Stable Ischemic Heart Disease: A double-blind, randomized placebo-controlled trial - NI

Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt of India0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1.Patients with complaints of chest discomfort at least once in the last 12 months.
•2.Patients wth a 10-year WHO CVD risk prediction score (South Asia-Bangladesh, Bhutan, India, Nepal, Pakistan) of 10% and above in either laboratory or non-laboratory-based charts. All such patients shall be screened for SIHD by ECG.
•3.Patient demonstrating ST segment depression by 1mm or more on Stress ECG (Exercise tolerance test).
•4.Patients suffering from chest discomfort classified under CCS Functional Score Class I and II.
•5.If the patients have medicines for the condition as per the guideline-directed medical therapy shall be accepted (Statin, antihypertensives, aspirin, clopidogrel, and nitroglycerine).
•6.Patients with controlled Diabetes Mellitus, hypertension, and Hypothyroidism (if such co-morbidities are present).
•7.Patient willing to provide voluntary informed consent.

•1. Patients with a history of prior Myocardial Infarction or Coronary Vessel Revascularization.
•2. Patients suffering from know conditions of valvular heart diseases (except mild TR, MR), Structural defects of the heart like VSD, ASD, TOF, PDA, Pericarditis, Pericardial effusion, Rheumatic Heart Disease, Cardiac tamponade, Congenital heart disorders, and Conductive disorders of the heart.
•3. Patients having prior heart surgeries.
•4. Patients suffering from immunocompromised states like Tuberculosis, HIV-AIDS, cancer, under steroid therapy, chemotherapeutic agents, or radiotherapy.
•5. Patients having implant of pacemaker device.
•6. Pregnant and lactating mothers.
•7. Patients suffering from severe mental disorders.
•8. Not willing to provide informed consent.

发起方

Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt of India